abrdn Life Sciences Investors
HQL
$17.08
$0.130.77%
| Weiss Ratings | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | abrdn Inc. | |||
| Manager/Tenure (Years) | Jason C. Akus (2) | |||
| Website | http://www.abrdn.com/us | |||
| Fund Information | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | abrdn Life Sciences Investors | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | May 08, 1992 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.07% | |||
| Asset Allocation | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 3.52% | |||
| Stock | 90.18% | |||
| U.S. Stock | 80.72% | |||
| Non-U.S. Stock | 9.46% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 4.71% | |||
| Convertible | 0.01% | |||
| Other Net | 1.57% | |||
| Price History | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.74% | |||
| 30-Day Total Return | 3.08% | |||
| 60-Day Total Return | 5.22% | |||
| 90-Day Total Return | 11.05% | |||
| Year to Date Total Return | 10.25% | |||
| 1-Year Total Return | 57.41% | |||
| 2-Year Total Return | 57.99% | |||
| 3-Year Total Return | 67.91% | |||
| 5-Year Total Return | 56.94% | |||
| Price | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $17.19 | |||
| 1-Month High Price | $18.22 | |||
| 52-Week Low Price | $12.31 | |||
| 52-Week Low Price (Date) | Jun 02, 2025 | |||
| 52-Week High Price | $18.22 | |||
| 52-Week High Price (Date) | May 06, 2026 | |||
| NAV | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $19.54 | |||
| 1-Month Low NAV | $18.78 | |||
| 1-Month High NAV | $20.30 | |||
| 52-Week Low NAV | $13.70 | |||
| 52-Week Low NAV (Date) | Jun 02, 2025 | |||
| 52-Week High NAV | $20.30 | |||
| 52-Week High Price (Date) | May 13, 2026 | |||
| Beta / Standard Deviation | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.93 | |||
| Standard Deviation | 17.60 | |||
| Balance Sheet | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 603.90M | |||
| Operating Ratios | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.35% | |||
| Turnover Ratio | 73.00% | |||
| Performance | HQL-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 45.72% | |||
| Last Bear Market Total Return | -8.89% | |||